Chao Yang
Chaozheng (Chao) Yang, Ph.D., currently serves as Sr Director of Data Science, leading the Data Science Center of Excellence in Commercial at Gilead Sciences. His role primarily focuses on delivering data science solutions that drive business impact, encompassing both global strategies and local affiliates execution. His expertise spans a wide array of data science methodologies including predictive modeling, driver analysis, resource optimization, marketing mix models, segmentation, test and control, patient journey analysis, DS AI Governance, application of Generative AI along with other advanced techniques.
Dr. Yang brings over 15 years of industry experience using data science to inform decision-making processes. Prior to joining Gilead, he held positions in several Fortune 500 healthcare companies including Novartis, AstraZeneca, Elevance Health (Anthem), and DuPont. In those positions, he played instrumental roles in leading and supporting analytics initiatives, identifying data-driven insights to optimize business strategies.
-
11-Dec-2024Practitioners StageInnovating Healthcare with Synthetic Data: Balancing Risk, Reward, and Regulation